This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Find out where to locate cash back offers that do not charge fees. Enjoy rewards on your spending!
26,005 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Could the SanDisk brand—now part of Western Digital—spark a trillion-dollar valuation in five years? This article bre...
In June, gold and silver prices pulled back, pressuring Hycroft Mining, a Nevada-focused, single-mine precious metals...
The beaten-down Figma shares rebound has investors weighing future growth, margins, and valuation. This guide breaks ...
Rivian shocks investors by cutting jobs shortly after starting to deliver the R2. This move raises questions about ho...
Lucid Group has ambitious plans, but shifting from carmaker to tech supplier brings new risks. This article explains ...
A stock that utterly failed decade may finally turn the corner. This guide breaks down three tangible reasons for a p...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
The past year reshaped The Trade Desk in ways that matter to investors. This article breaks down what changed, why it...